These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 20932408)

  • 1. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
    Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical versus partial nephrectomy: effect on overall and noncancer mortality.
    Zini L; Perrotte P; Capitanio U; Jeldres C; Shariat SF; Antebi E; Saad F; Patard JJ; Montorsi F; Karakiewicz PI
    Cancer; 2009 Apr; 115(7):1465-71. PubMed ID: 19195042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
    Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
    Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
    Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
    Capitanio U; Perrotte P; Zini L; Jeldres C; Shariat SF; Isbarn H; Arjane P; Peloquin F; Pharand D; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Sep; 104(6):795-9. PubMed ID: 19389018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
    Capitanio U; Zini L; Perrotte P; Shariat SF; Jeldres C; Arjane P; Pharand D; Widmer H; Péloquin F; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2008 Nov; 72(5):1090-5. PubMed ID: 18799207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities.
    Sun M; Bianchi M; Trinh QD; Hansen J; Abdollah F; Hanna N; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    BJU Int; 2013 Jan; 111(1):67-73. PubMed ID: 22612472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.
    Jeldres C; Patard JJ; Capitanio U; Perrotte P; Suardi N; Crepel M; Ficarra V; Cindolo L; de La Taille A; Tostain J; Pfister C; Albouy B; Colombel M; Méjean A; Lang H; Jacqmin D; Bernhard JC; Ferrière JM; Bensalah K; Karakiewicz PI
    Urology; 2009 Jun; 73(6):1300-5. PubMed ID: 19376568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment management of small renal masses in the 21st century: a paradigm shift.
    Sun M; Abdollah F; Bianchi M; Trinh QD; Jeldres C; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    Ann Surg Oncol; 2012 Jul; 19(7):2380-7. PubMed ID: 22322956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
    Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
    Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis.
    Sun M; Abdollah F; Bianchi M; Trinh QD; Jeldres C; Tian Z; Shariat SF; Widmer H; Zorn K; Menon M; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2011 Dec; 60(6):1152-9. PubMed ID: 21868147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
    Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
    Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
    Marchioni M; Preisser F; Bandini M; Nazzani S; Tian Z; Kapoor A; Cindolo L; Abdollah F; Tilki D; Briganti A; Montorsi F; Shariat SF; Schips L; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.
    Zini L; Perrotte P; Jeldres C; Capitanio U; Duclos A; Jolivet-Tremblay M; Arjane P; Péloquin F; Pharand D; Villers A; Montorsi F; Patard JJ; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):899-904; discussion 904. PubMed ID: 19154499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
    Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.